Bilcare Ltd.
Snapshot View

64.60 +0.45 ▲0.7%

27 May 2022, 04:01:00 PM
Volume: 13,071

Overview View Details

Sector Plastic Products Compare with Sector peers
Industry Plastic Products Compare with Industry peers
Website http://www.bilcare.com
Market Cap 152.10 Cr.
Enterprise Value(EV) 842.03 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -5.35 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 21.33 Trailing Twelve Months Ending 2022-03
Book Value / Share 31.92 Trailing Twelve Months Ending 2022-03
Price to Book Value 2.02 Calculated using Price: 64.60
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.35 Cr. 23,545,231 Shares
FaceValue 10
Company Profile

Bilcare, incorporated in the year 1987, is engaged in manufacturing pharmaceutical packaging. It has an experience of working with 500 pharma manufacturing companies worldwide.Bilcare is a global leader and an innovation-led packaging solutions provider that partners with the pharmaceutical industry to improve patient healthcare outcomes. The company endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients.

Bilcare PPI offers Innovative Pharmaceutical Packaging Solutions comprising of a wide range of specialty Polymer Films and Aluminum Foils mainly used for packaging of solid dosage pharmaceutical products.

Bilcare GCS provides Global Clinical Material Supplies for new drug discovery projects.

Bilcare Technologies provides Anti-counterfeit (ncID - nonclonableID) solutions for product & people ID authentication and security
The company develops design keeping various aspects into consideration such as end-user, optimum material, composite dosages, on-pack communication, cost-effective, regulatory requirements, etc.It also offers pharmaceutical research and clinical services.

It has representative offices located in Argentina, Bangladesh, Chile, Colombia, Czech Republic, Egypt, France, Indonesia, Iran, Israel, Italy, Jordan, South Korea, Malaysia, Mexico, Pakistan, Saudi Arabia, South Africa, Spain, Taiwan, Thailand, Turkey, Venezuela and Vietnam.

It maintains quality standards prescribed by various agency such USFDA, DEA, IQA, SAP, ISO 9001 and 14001.Bilcare has a global customer base and customers comprise many of the largest global pharmaceutical companies viz. Bristol-Myers Squibb, Dr. Reddy’s, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Ranbaxy, Sanofi-Aventis, Teva to name a few. Bilcare has a strong customer base of over 2,500 customers in over 50 countries worldwide.

For packaging purposes the company uses material like blister films range, aluminium foils, cold formed blisters, wrap systems, closures & containers, flexibles and eco-friendly paper composites.

Bilcare Singapore Pte a wholly owned subsidiary acquired 100 percent stakes in Singapore-based Singular ID. The firm specialises in technology to identify fake drugs.

In 2010 Bilcare won Pharmexcil / Govt of India Patent Award-2009-10.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+0.70%
1 Week
-7.18%
1 Month
-14.72%
3 Month
-2.64%
6 Month
-16.59%
1 Year
+10.52%
2 Year
+157.88%
5 Year
+11.76%
10 Year
-58.87%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 4.38 -9.38 -14.86 -9.09 -12.03 -39.29 -274.69 -515.03 -11.48
Return on Capital Employed (%) 7.96 3.36 1.16 -1.40 4.40 1.64 -6.38 4.01 6.41
Return on Assets (%) 1.40 -2.83 -4.13 -2.07 -2.26 -5.81 -13.97 -4.82 -1.13

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 1,325 1,324 1,096 713 614 400 -70 108 86 75
Non Curr. Liab. 2,050 2,126 2,228 2,090 2,036 960 1,024 535 477 449
Curr. Liab. 989 866 966 758 745 1,978 2,069 311 314 403
Minority Int. 54 53 49 59 62 63 64 68 78 86
Equity & Liab. 4,419 4,368 4,340 3,620 3,457 3,402 3,087 1,023 955 1,013
Non Curr. Assets 2,407 2,444 2,293 2,713 2,669 2,469 2,205 657 618 592
Curr. Assets 2,012 1,924 2,047 907 788 933 882 365 337 421
Misc. Exp. not W/O
Total Assets 4,419 4,368 4,340 3,620 3,457 3,402 3,087 1,023 955 1,013

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 3,547 3,062 2,692 2,603 2,633 2,778 2,997 1,827 623 845
Other Income 20 18 46 30 39 34 60 97 18 15
Total Income 3,567 3,080 2,738 2,633 2,672 2,813 3,057 1,924 641 859
Total Expenditure -3,175 -2,823 -2,507 -2,396 -2,445 -2,621 -2,829 -1,782 -572 -784
PBIDT 392 257 231 237 227 192 229 142 69 75
Interest -167 -217 -236 -151 -176 -249 -283 -174 -76 -69
Depreciation -148 -141 -191 -164 -177 -416 -378 -239 -46 -39
Taxation -19 -23 16 112 -24 8 -21 15 14 0
Exceptional Items -117 70 267 157 27 29
PAT 57 -124 -180 -82 -80 -199 -453 -99 -11 -4
Minority Interest -5 1 0 -3 -5 -2 -2 -5 -10 -8
Share Associate
Other Related Items
Consolidated Net Profit 40 -113 -216 -85 -85 -201 -458 -104 -21 -13
Adjusted EPS 22 -52 -76 -36 -36 -85 -193 -44 -9 -5

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 92 227 314 -315 177 300 98 206 256 72
Cash Fr. Inv. -383 -966 -351 247 -358 -129 -203 -104 1,309 2
Cash Fr. Finan. 285 661 48 119 149 -155 91 -103 -1,600 -83
Net Change -5 -78 12 50 -32 16 -13 -1 -35 -9
Cash & Cash Eqvt 173 94 106 156 73 90 77 76 41 32

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01
Public 69.99 69.99 69.99 69.99 69.99 69.99 69.99 69.99 69.99
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 1.39 1.39 1.39 1.39 1.39 1.39 1.39 1.39 1.39

Announcements View Details

Thu, 26 May 2022
Compliances-Reg.24(A)-Annual Secretarial Compliance
Submission of Secretarial Compliance Report
Wed, 25 May 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Audited Results for the quarter and year ended 31st March 22
Mon, 23 May 2022
Board Meeting Outcome for Submission Of Audited Financial Results Under Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter And Year Ended 31 March 2022.
Submission of Audited Financial Results under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the quarter and year ended 31 March 2022.

Technical Scans View Details

Fri, 27 May 2022
Opening at High Opening at High
High Decrease 1 Month High Decrease 1 Month
High Increase 2 Years High Increase 2 Years
CCI Bullish CCI Bullish
MFI Trending Up MFI Trending Up

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Astral Ltd. 34,297.07 1,707.00 +2.6%
Supreme Industries Ltd. 22,689.54 1,786.20 +3.7%
Finolex Industries Ltd. 8,996.92 145.00 +4.1%
Polyplex Corporation Ltd. 7,069.58 2,252.00 +0.3%
Prince Pipes and Fittings Ltd. 7,003.49 633.45 +1.3%
EPL Ltd. 5,140.80 162.75 +1.5%
Jindal Poly Films Ltd. 4,766.59 1,088.60 +20.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Astral Ltd. Consolidated 2021-12 66.34 1,707.00 +2.6%
Supreme Industries Ltd. Consolidated 2022-03 23.43 1,786.20 +3.7%
Finolex Industries Ltd. Consolidated 2022-03 8.56 145.00 +4.1%
Polyplex Corporation Ltd. Consolidated 2022-03 12.43 2,252.00 +0.3%
Prince Pipes and Fittings Ltd. Standalone 2022-03 28.08 633.45 +1.3%
EPL Ltd. Consolidated 2022-03 23.98 162.75 +1.5%
Jindal Poly Films Ltd. Consolidated 2021-12 5.10 1,088.60 +20.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Astral Ltd. Consolidated 2021-12 15.45 1,707.00 +2.6%
Supreme Industries Ltd. Consolidated 2022-03 5.90 1,786.20 +3.7%
Finolex Industries Ltd. Consolidated 2022-03 2.29 145.00 +4.1%
Polyplex Corporation Ltd. Consolidated 2022-03 2.13 2,252.00 +0.3%
Prince Pipes and Fittings Ltd. Standalone 2022-03 5.54 633.45 +1.3%
EPL Ltd. Consolidated 2022-03 2.82 162.75 +1.5%
Jindal Poly Films Ltd. Consolidated 2021-12 1.43 1,088.60 +20.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Astral Ltd. Consolidated 2021-03 0.04 1,707.00 +2.6%
Supreme Industries Ltd. Consolidated 2021-03 0.00 1,786.20 +3.7%
Finolex Industries Ltd. Consolidated 2021-03 0.06 145.00 +4.1%
Polyplex Corporation Ltd. Consolidated 2021-03 0.23 2,252.00 +0.3%
Prince Pipes and Fittings Ltd. Standalone 2021-03 0.08 633.45 +1.3%
EPL Ltd. Consolidated 2021-03 0.33 162.75 +1.5%
Jindal Poly Films Ltd. Consolidated 2021-03 0.35 1,088.60 +20.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Astral Ltd. Consolidated 2021-03 24.46 1,707.00 +2.6%
Supreme Industries Ltd. Consolidated 2021-03 30.65 1,786.20 +3.7%
Finolex Industries Ltd. Consolidated 2021-03 28.16 145.00 +4.1%
Polyplex Corporation Ltd. Consolidated 2021-03 28.35 2,252.00 +0.3%
Prince Pipes and Fittings Ltd. Standalone 2021-03 23.65 633.45 +1.3%
EPL Ltd. Consolidated 2021-03 15.25 162.75 +1.5%
Jindal Poly Films Ltd. Consolidated 2021-03 35.18 1,088.60 +20.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Astral Ltd. Consolidated 2021-03 24.46 1,707.00 +2.6%
Supreme Industries Ltd. Consolidated 2021-03 30.65 1,786.20 +3.7%
Finolex Industries Ltd. Consolidated 2021-03 28.16 145.00 +4.1%
Polyplex Corporation Ltd. Consolidated 2021-03 28.35 2,252.00 +0.3%
Prince Pipes and Fittings Ltd. Standalone 2021-03 23.65 633.45 +1.3%
EPL Ltd. Consolidated 2021-03 15.25 162.75 +1.5%
Jindal Poly Films Ltd. Consolidated 2021-03 35.18 1,088.60 +20.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Astral Ltd. Consolidated 2021-03 3,176.30 1,707.00 +2.6%
Supreme Industries Ltd. Consolidated 2021-03 6,357.06 1,786.20 +3.7%
Finolex Industries Ltd. Consolidated 2021-03 3,462.82 145.00 +4.1%
Polyplex Corporation Ltd. Consolidated 2021-03 4,918.27 2,252.00 +0.3%
Prince Pipes and Fittings Ltd. Standalone 2021-03 2,071.52 633.45 +1.3%
EPL Ltd. Consolidated 2021-03 3,091.60 162.75 +1.5%
Jindal Poly Films Ltd. Consolidated 2021-03 4,082.28 1,088.60 +20.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Astral Ltd. Consolidated 2021-03 415.20 1,707.00 +2.6%
Supreme Industries Ltd. Consolidated 2021-03 832.15 1,786.20 +3.7%
Finolex Industries Ltd. Consolidated 2021-03 721.60 145.00 +4.1%
Polyplex Corporation Ltd. Consolidated 2021-03 861.96 2,252.00 +0.3%
Prince Pipes and Fittings Ltd. Standalone 2021-03 221.83 633.45 +1.3%
EPL Ltd. Consolidated 2021-03 245.20 162.75 +1.5%
Jindal Poly Films Ltd. Consolidated 2021-03 790.88 1,088.60 +20.0%